论文部分内容阅读
支气管肺发育不良(BPD)与新生儿期在经历了数天至数周之内的各种呼吸损伤后而发生不同程度的肺纤维化有关,BPD是气肿性慢性肺疾病(CLD)的一种形式,也是现代新生儿监护的严重并发症和引起1岁以内婴儿发病率和死亡率的重要原因。已确诊为BPD的患儿使用糖皮质激素疗法是有效的,但对早产婴儿可能存在严重的后遗症。为探讨早期使用地塞米松可以防止CLD的发生并对使用表面活性
Bronchopulmonary dysplasia (BPD) is associated with varying degrees of pulmonary fibrosis following various respiratory injuries in the neonatal period, ranging from days to weeks. BPD is one of the most common causes of emphysematous chronic lung disease (CLD) The form is also a serious complication of modern neonatal care and an important cause of infant morbidity and mortality within 1 year of age. Glucocorticoid therapy is effective in children who have been diagnosed with BPD but may have severe sequelae in premature infants. To explore the early use of dexamethasone can prevent the occurrence of CLD and the use of surface activity